Fredun Pharmaceuticals P/B Ratio
Fredun Pharmaceuticals P/B ratio. Fredun Pharmaceuticals (FREDUN) P/B ratio is 8.53 (High), book value per share ₹463.33 vs Healthcare average P/B of 0.01 — Very High - Significant premium, high growth expectations or speculative. Analyse Fredun Pharmaceuticals shareholding analysis to track promoter, FII and institutional holdings.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
FREDUN P/B Ratio — Valuation Insights & Book Value Analysis
Fredun Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 8.53 (High). View Fredun Pharmaceuticals yearly highs lows for the annual high/low range and current price position.
- Stock appears overvalued with PB of 8.53, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 99.8% above historical average
- Trading at premium to sector average PB of 0.01
Fredun Pharmaceuticals P/B Ratio Historical Trend
FREDUN annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see FREDUN share price screener.
FREDUN Historical P/B Ratio — Book Value Per Share & Year-End Price
Fredun Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 2.94 | ₹463.33 | ₹1363.20 | ₹278 | Moderate |
| 2025 | 5.6 | ₹282.0 | ₹1578.30 | ₹141 | High |
FREDUN vs Healthcare Peers — P/B Ratio Comparison
Fredun Pharmaceuticals P/B 8.53 vs Healthcare average 0.01, median 0.65 — range -6.55–1.13.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹47 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |